ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

NIAID Names Tramont Director, Division Of AIDS.

July 20, 2001

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010